| Literature DB >> 29133985 |
Abstract
BACKGROUND: Adolescent pregnancy is a global public health problem, particularly repeated pregnancy. The best strategy to lower prevalence of adolescent pregnancy and repeated pregnancy is promoting highly effective long-acting contraceptive methods along with special counseling programs. Long-acting reversible contraception (LARC) is the ideal contraceptive of choice for adolescents. It is not known whether immediate postpartum contraceptive counseling increases postpartum LARC use in adolescents.Entities:
Keywords: adolescent; contraception; contraceptive counseling; immediate postpartum contraceptive counseling; long-acting reversible contraception (LARC)
Year: 2017 PMID: 29133985 PMCID: PMC5669788 DOI: 10.2147/AHMT.S148434
Source DB: PubMed Journal: Adolesc Health Med Ther ISSN: 1179-318X
Figure 1Trial flow of the study population and the number of adolescent mothers in each group.
Baseline characteristics of adolescent mothers comparing immediate with conventional postpartum contraceptive counseling
| Characteristics | Total (n=233) | Immediate postpartum counselling (n=118) | Conventional postpartum counselling (n=115) | Odds ratio (95% CI) | |
|---|---|---|---|---|---|
| Age (mean ± SD) | 17.19±1.73 | 17.23±1.61 | NA | 0.862 | |
| 12–16 years | 77 (33) | 40 (33.9) | 37 (32.2) | 1.081 | 0.780 |
| 17–19 years | 156 (67) | 78 (66.1) | 78 (67.8) | (0.63–1.87) | |
| BMI | 22.78±3.69 | 22.46±3.77 | NA | 0.509 | |
| Marital status | |||||
| Single | 73 (31.3) | 32 (27.1) | 41 (35.7) | 0.672 | 0.160 |
| Married | 160 (68.7) | 86 (72.9) | 74 (64.3) | (0.39–1.17) | |
| Education | |||||
| Primary and elementary school | 46 (19.7) | 21 (17.8) | 25 (21.7) | 0.779 | 0.450 |
| Secondary school and higher | 187 (81.3) | 97 (82.2) | 90 (78.3) | (0.41–1.49) | |
| Occupation | |||||
| None and studying | 167 (71.7) | 85 (72) | 82 (71.3) | 1.037 | 0.902 |
| Yes (employee and merchant) | 66 (28.3) | 33 (28) | 33 (28.7) | (0.59–1.83) | |
| Income | |||||
| <10,000 baht/month | 153 (65.7) | 77 (65.3) | 76 (66.1) | 0.849 | 0.894 |
| ≥10,000 baht/month | 80 (34.3) | 41 (34.7) | 39 (33.9) | (0.56–1.66) | |
| Parity | |||||
| Primipara | 195 (83.7) | 101 (85.6) | 94 (81.7) | 1.327 | 0.426 |
| Multipara | 38 (16.3) | 17 (14.4) | 21 (18.3) | (0.66–2.67) | |
| GA at first ANC | |||||
| 1 –12 weeks | 101 (43.3) | 46 (39) | 55 (47.8) | 0.697 | 0.173 |
| >12 weeks | 132 (56.7) | 72 (61) | 60 (52.2) | (0.41–1.17) | |
| Number of ANC | |||||
| ≤4 | 66 (28.3) | 30 (25.4) | 36 (31.1) | 0.748 | 0.319 |
| >4 | 167 (71.7) | 88 (74.6) | 79 (68.7) | (0.42–1.36) | |
| Mode of delivery | |||||
| Vaginal delivery | 205 (88.0) | 104 (88.1) | 101 (87.8) | 1.030 | 0.942 |
| Cesarean section | 28 (12.0) | 14 (11.9) | 14 (12.2) | (0.47–2.27) | |
Note: Data are presented as number (%).
Abbreviations: ANC, antenatal care; GA, gestational age; NA, not applicable.
Postpartum contraceptive use and contraceptive behavior of adolescent mothers
| Contraceptive behavior | Total (n=233) | Immediate postpartum counselling (n=118) | Conventional postpartum counselling (n=115) | Odds ratio (95% CI) | |
|---|---|---|---|---|---|
| Yes (intended) | 84 (36.1) | 38 (32.2) | 46 (40.0) | 0.731 | 0.215 |
| No (unintended) | 149 (63.9) | 80 (67.8) | 69 (60.0) | (0.42–1.22) | |
| Yes | 179 (76.8) | 90 (76.3) | 89 (77.4) | 0.939 | 0.839 |
| No | 54 (23.2) | 28 (23.7) | 26 (22.6) | (0.52–1.73) | |
| LARC | 7 (3.0) | 1 (0.8) | 6 (5.2) | 0.155 | 0.063 |
| Non-LARC | 226 (97.0) | 117 (99.2) | 109 (94.8) | (0.02–1.31) | |
| Condom | 60 (25.8) | 36 (30.5) | 24 (20.9) | NA | 0.167 |
| Pills | 112 (48.1) | 54 (45.8) | 58 (50.4) | ||
| Injection | 14 (6.0) | 6 (5.1) | 8 (7.0) | ||
| IUD and implant | 7 (3.0) | 1 (0.8) | 6 (5.2) | ||
| No contraception | 40 (17.1) | 21 (17.8) | 19 (16.5) | ||
| <3 years | 9 (3.9) | 4 (3.4) | 5 (4.3) | 0.772 | 0.764 |
| ≥3 years | 224 (96.1) | 114 (96.6) | 110 (95.7) | (0.20–2.95) | |
| LARC | 54 (23.2) | 30 (25.4) | 24 (20.9) | 1.293 | 0.410 |
| Non-LARC | 179 (76.8) | 88 (74.6) | 91 (79.1) | (0.70–2.38) | |
| Condom | 21 (9.0) | 11 (9.3) | 10 (8.7) | NA | 0.775 |
| Pills | 84 (36.1) | 39 (33.1) | (39.1) | ||
| Injection | 62 (26.6) | 30 (25.4) | 32 (27.8) | ||
| IUD | 11 (4.7) | 6 (5.1) | 5 (4.3) | ||
| Implant | 43 (18.5) | 24 (20.3) | 19 (16.5) | ||
| No contraception | 12 (5.1) | 8 (6.8) | 4 (3.5) | ||
| LARC | 136 (58.4) | 87 (73.7) | 49 (42.6) | 3.780 | <0.001 |
| Non-LARC | 97 (41.6) | 31 (26.3) | 66 (57.4) | (2.18–6.57) | |
| Condom | 14 (6.0) | 6 (5.1) | 8 (7) | NA | <0.001 |
| Pills | 25 (10.7) | 6 (5.1) | (16.5) | ||
| Injection | 49 (21.0) | 19 (16.1) | 30 (26.1) | ||
| IUD | 18 (7.7) | 13 (11.0) | 5 (4.3) | ||
| Implant | 118 (50.6) | 74 (62.7) | 44 (38.3) | ||
| No contraception | 9 (3.8) | 0 (0) | 9 (7.8) | ||
Notes: Data are presented as number (%).
Fisher’s exact test. LARC consists of IUD and implant; NA, not applicable; Non-LARC consists of condom, pills, injection and no contraception.
Abbreviations: IUD, intra-uterine device; LARC, long-acting reversible contraception.
Univariate and multivariate regression analysis of factors predicting LARC use in postpartum adolescents
| Factors | Univariate analysis
| Multivariate analysis
| ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | ORadj | 95% CI | |||
| 12–16 years | 1.00 | Reference | ||||
| 17–19 years | 1.08 | (0.62–1.87) | 0.790 | NA | NA | NA |
| Single | 1.00 | Reference | ||||
| Married | 1.05 | (0.60–1.84) | 0.861 | NA | NA | NA |
| Primary and elementary school | 1.00 | Reference | 1.00 | Reference | ||
| Secondary school and higher | 6.7 | (1.96–22.67) | 0.002 | 1.503 | (0.75–3.06) | 0.255 |
| No | 1.00 | Reference | ||||
| Yes | 0.96 | (0.54–1.70) | 0.877 | NA | NA | NA |
| No | 1.00 | Reference | ||||
| Yes | 1.33 | (0.71–2.48) | 0.378 | NA | NA | NA |
| Yes | 1.00 | Reference | ||||
| No | 1.05 | (0.57–1.95) | 0.880 | NA | NA | NA |
| Intended | 1.00 | Reference | 1.00 | Reference | ||
| Unintended | 1.58 | (0.92–2.7) | 0.096 | 1.408 | (0.79–2.51) | 0.244 |
| LARC | 1.00 | Reference | ||||
| Non-LARC | 1.05 | (0.23–4.82) | 0.947 | NA | NA | NA |
| Primipara | 2.25 | (1.07–4.72) | 0.032 | 1.429 | (0.68–3.06) | 0.358 |
| Multipara | 1.00 | Reference | 1.00 | Reference | ||
| 1–12 weeks | 1.00 | Reference | ||||
| >12 weeks | 0.93 | (0.55–1.57) | 0.779 | NA | NA | NA |
| ≤4 | 1.00 | Reference | ||||
| >4 | 1.05 | (0.59–1.86) | 0.877 | NA | NA | NA |
| Vaginal delivery | 1.00 | Reference | ||||
| Cesarean section | 1.12 | (0.50–2.51) | 0.788 | NA | NA | NA |
| Yes | 3.37 | (1.32–8.61) | 0.011 | 3.67 | 2.10–6.41 | <0.001 |
| No | 1.00 | Reference | 1.00 | Reference | ||
Notes:
Crude OR estimated by Binary logistic regression.
Adjusted OR estimated by multiple logistic regression adjusting for education, pregnancy intention, parity and immediate counseling.
Abbreviations: ANC, antenatal care; GA, gestational age; LARC, long-acting reversible contraception; NA, not applicable; OR, odds ratio; ORadj, adjusted odds ratio.